Co-administration of sodium selenite and sodium arsenite exacerbates hepatic, renal, pulmonary and splenic inflammation in rats
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
This study examined the effect of co-administration of sodium selenite (SS) and sodium arsenite (SA) on inflammation in rats. Thirty (30) male Wistar rats were separated into 6 groups of five animals each. Group I (control) was given distilled water, groups II, III, IV and V were exposed to 20 and 40 ppm SA in drinking water, but in addition to that, groups IV and V only were co-exposed with 0.25 mg/kg bwt SS, while group VI was exposed to 0.25 mg/kg bwt SS only orally. Following 5 weeks of exposure, levels of pro-inflammatory cytokines (TNF- α, IL-1 βand IL-6) were increased in SA-exposed groups. Synergistic and antagonistic effects were observed in co-exposed groups depending on dose and the spe- cific tissue being considered. Synergism was observed in tissues co-exposed to higher dose (40 ppm) of SA + 0.25 mg/kgbwt SS except in the liver, where these markers were de- creased compared with control. Level of IL-10 (anti-inflammatory marker) decreased in all the tissues investigated except in the lungs of animals co-exposed with 40 ppm SA. There was alteration in tissue architecture, revealing steatosis and hemorrhagic lesions as the common features in co-exposed groups. Results obtained indicate that the dose of SS used in this study may be toxic and not therapeutic against SA-induced tissue inflammation in rats.
Description
Keywords
Sodium selenite, Sodium arsenite, Inflammatory cytokines, Liver, Kidney, Lung, Spleen
